Ten-year survival rate of stage 1b gastric cancer

The 10-year survival rate for stage 1b gastric cancer is usually around 50%-60%, but the specific situation varies depending on the patient's treatment plan, physical condition, lifestyle and other factors. Treatment includes radical treatment with surgery as the main method, supplemented by preoperative or postoperative chemotherapy. At the same time, regular follow-up and health management are also important links to ensure long-term survival.

1. What is stage 1b gastric cancer?

Stage 1b gastric cancer is an early stage of gastric cancer. Its cancer cells generally only invade the gastric submucosal layer and may have a small amount of lymph node metastasis (limited to 1-2 lymph nodes). In this case, the cancer has spread to a low degree and has a relatively good treatment window. Compared with advanced gastric cancer, the treatment effect and survival rate of patients with stage 1b gastric cancer are significantly improved. Timely diagnosis and appropriate treatment are the key.

2. Treatments that improve the 10-year survival rate

To maximize the 10-year survival rate of patients with stage 1b gastric cancer, treatment strategies usually include the following aspects:

Surgery

Surgery is the main treatment for stage 1b gastric cancer. The goal is to completely remove the gastric tissue where the tumor is located and the surrounding lymph nodes. There are three common methods:

- Partial gastrectomy: Suitable for patients with a clear tumor location and a small lesion area;

- Radical gastrectomy: If the tumor is large or involves multiple areas, your doctor may recommend removing the entire stomach.

-Laparoscopic minimally invasive surgery: less trauma, faster recovery, can be used for some eligible patients with early gastric cancer.

Adjuvant chemotherapy

Postoperative chemotherapy can remove tiny cancer cells that were not completely eliminated by surgery and reduce the risk of recurrence. Common chemotherapy regimens include oxaliplatin combined with fluorouracil (FOLFOX). Preoperative chemotherapy can also effectively shrink tumors and increase the success rate of surgery in some cases.

Targeted therapy (for some patients)

Overexpression of the HER2 gene may be detected in some patients with stage 1b gastric cancer. Targeted drugs targeting this specific gene (such as trastuzumab) can help inhibit the growth and spread of cancer cells and further improve prognosis.

3. Importance of health management and follow-up

Long-term health management after treatment is critical to prolonging survival:

- Regular follow-up: Endoscopic examination, imaging test and tumor marker monitoring are required regularly after surgery to detect signs of recurrence or metastasis in a timely manner;

- Improve your lifestyle: quit smoking and limit alcohol consumption, avoid high-salt and pickled foods, eat more fiber-rich vegetables and fruits, and develop a reasonable diet plan;

-Psychological support and rehabilitation training: A positive mental state can help improve immune function. If necessary, you can seek help from a psychologist or join a cancer patient support group.

The 10-year survival rate of stage 1b gastric cancer is relatively high, but it depends on early diagnosis, standardized treatment and long-term health management. The key to treatment at this stage is the combination of radical surgery and adjuvant chemotherapy. Patients should have regular checkups after surgery and adjust their lifestyle to better prolong survival time and improve their quality of life.